NewAmsterdam Pharma Co. NV (NAMS)
27.32
+0.46
(+1.73%)
USD |
NASDAQ |
Aug 25, 16:00
27.34
+0.02
(+0.09%)
After-Hours: 19:48
NewAmsterdam Pharma Gross Profit Margin (Quarterly) : 98.41% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 98.41% |
| March 31, 2026 | 97.96% |
| December 31, 2025 | -84.38% |
| September 30, 2025 | 81.61% |
| June 30, 2025 | 99.76% |
| Date | Value |
|---|---|
| March 31, 2025 | 98.25% |
| December 31, 2024 | 99.60% |
| September 30, 2024 | 99.90% |
| June 30, 2024 | 99.17% |
| March 31, 2024 | 98.93% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| ProQR Therapeutics NV | 91.93% |
| Pharming Group NV | 80.56% |
| argenx SE | -- |
| Arcutis Biotherapeutics, Inc. | 91.58% |
| Damora Therapeutics, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -37.21% |
| Return on Assets | -34.07% |
| Return on Invested Capital | -37.20% |
| Profit Margin (Quarterly) | -1.73K% |
| Operating Margin (Quarterly) | -1.75K% |
| Return on Net Operating Assets | -1.87K% |